Literature DB >> 25733586

Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.

Dean Ironmonger1, Obaghe Edeghere2, Amardeep Bains2, Richard Loy3, Neil Woodford3, Peter M Hawkey4.   

Abstract

OBJECTIVES: To retrospectively analyse routine susceptibility testing data to describe antimicrobial non-susceptibility trends in isolates of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa from urine samples in a population of 5.6 million people over a 4 year period.
METHODS: De-duplicated laboratory data submitted to the AmSurv surveillance system from the West Midlands region of England and results of submissions to the Antimicrobial Resistance and Healthcare Associated Infections Reference Unit were extracted for the period 2010-13. Descriptive analysis of the non-susceptibility of selected Gram-negative organisms to key antibiotics, as recommended for monitoring in the UK Five Year Antimicrobial Resistance Strategy, was undertaken.
RESULTS: During the study period, there were 431 461 reports for E. coli, 23 786 for K. pneumoniae and 6985 for P. aeruginosa from urine specimens. These represented 61%, 3% and 1%, respectively, of all organisms isolated from urine specimens. There was a linear increase in non-susceptibility to third-generation cephalosporins for E. coli and K. pneumoniae, and to ciprofloxacin for E. coli, in specimens from both hospital and community settings (P < 0.001). The proportions of E. coli and K. pneumoniae reported non-susceptible to meropenem and/or imipenem remained low during the study period, with no evidence of linear trend (P ≥ 0.05).
CONCLUSIONS: Automated antimicrobial resistance surveillance enabled, for the first time in England, the systematic monitoring of resistance in bacteria responsible for urinary tract infections in a defined population, and thereby provided a representative indication of the burden of resistance in Gram-negative bacteria in hospital and community settings. © Crown copyright 2015.

Entities:  

Keywords:  Gram-negative; UTIs; antibiotic resistance; epidemiology; microbiology

Mesh:

Substances:

Year:  2015        PMID: 25733586     DOI: 10.1093/jac/dkv043

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Imipenem-Relebactam Susceptibility Testing of Gram-Negative Bacilli by Agar Dilution, Disk Diffusion, and Gradient Strip Methods Compared with Broth Microdilution.

Authors:  Hanna Hakvoort; Evelyn Bovenkamp; Kerryl E Greenwood-Quaintance; Suzannah M Schmidt-Malan; Jay N Mandrekar; Audrey N Schuetz; Robin Patel
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

2.  Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014.

Authors:  P J Stapleton; D J Lundon; R McWade; N Scanlon; M M Hannan; F O'Kelly; M Lynch
Journal:  Ir J Med Sci       Date:  2017-01-04       Impact factor: 1.568

3.  The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.

Authors:  James R Johnson; Paul Thuras; Brian D Johnston; Scott J Weissman; Ajit P Limaye; Kim Riddell; Delia Scholes; Veronika Tchesnokova; Evgeni Sokurenko
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

4.  Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study.

Authors:  Christopher C Butler; Nick Francis; Emma Thomas-Jones; Carl Llor; Emily Bongard; Michael Moore; Paul Little; Janine Bates; Mandy Lau; Timothy Pickles; Micaela Gal; Mandy Wootton; Nigel Kirby; David Gillespie; Kate Rumbsy; Curt Brugman; Kerenza Hood; Theo Verheij
Journal:  Br J Gen Pract       Date:  2017-12       Impact factor: 5.386

5.  Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.

Authors:  Wellington Francisco Rodrigues; Camila Botelho Miguel; Ana Paula Oliveira Nogueira; Carlos Ueira-Vieira; Tony De Paiva Paulino; Siomar De Castro Soares; Elisabete Aparecida Mantovani Rodrigues De Resende; Javier Emilio Lazo-Chica; Marcelo Costa Araújo; Carlo José Oliveira
Journal:  Int J Environ Res Public Health       Date:  2016-09-15       Impact factor: 3.390

6.  Routine laboratory surveillance of antimicrobial resistance in community-acquired urinary tract infections adequately informs prescribing policy in England.

Authors:  Vicky Watts; Benjamin Brown; Maria Ahmed; André Charlett; Carolyn Chew-Graham; Paul Cleary; Valerie Decraene; Kirsty Dodgson; Ryan George; Susan Hopkins; Aneez Esmail; William Welfare
Journal:  JAC Antimicrob Resist       Date:  2020-05-27

7.  Invasion and diversity in Pseudomonas aeruginosa urinary tract infections.

Authors:  J N Newman; R V Floyd; J L Fothergill
Journal:  J Med Microbiol       Date:  2022-03       Impact factor: 3.196

8.  A Comparative Analysis of the Mechanism of Toll-Like Receptor-Disruption by TIR-Containing Protein C from Uropathogenic Escherichia coli.

Authors:  Anna Waldhuber; Greg A Snyder; Franziska Römmler; Christine Cirl; Tina Müller; Tsan Sam Xiao; Catharina Svanborg; Thomas Miethke
Journal:  Pathogens       Date:  2016-02-29

9.  Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in Guadeloupe.

Authors:  Stéphanie Guyomard-Rabenirina; Joyce Malespine; Célia Ducat; Syndia Sadikalay; Mélanie Falord; Dorothée Harrois; Vincent Richard; Charles Dozois; Sébastien Breurec; Antoine Talarmin
Journal:  BMC Microbiol       Date:  2016-06-24       Impact factor: 3.605

10.  Antimicrobial Non-Susceptibility of Escherichia coli from Outpatients and Patients Visiting Emergency Rooms in Taiwan.

Authors:  Jann-Tay Wang; Shan-Chwen Chang; Feng-Yee Chang; Chang-Phone Fung; Yin-Ching Chuang; Yao-Shen Chen; Yih-Ru Shiau; Mei-Chen Tan; Hui-Ying Wang; Jui-Fen Lai; I-Wen Huang; Tsai-Ling Yang Lauderdale
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.